anmelden
25 € WM-Startbonus auf dein Cash-Konto
OMX Nordic 40
2.663,51
PKT
-29,19
PKT
-1,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.09.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 15.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 13.09.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 11.09.23 | AstraZeneca Overweight | Barclays Capital | |
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.09.23 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 06.09.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 06.09.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 05.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 04.09.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.08.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 21.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 18.08.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.08.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 15.08.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 14.08.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. |